Stephen Zimmer
Family Medicine · Denver, NCNPI 1457424046
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,395 and has fallen 98.3% since, to $24 in 2022.
Across 211 payments — averaging $14.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$441
- AbbVie$306
- Otsuka America Pharmaceutical, Inc.$270
- AstraZeneca$252
- Pfizer$228
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$147
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,956100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $441 |
| AbbVie(2 entities) | 28 | $306 |
| Otsuka America Pharmaceutical, Inc. | 15 | $270 |
| AstraZeneca(2 entities) | 16 | $252 |
| Pfizer | 23 | $228 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $147 |
| Daiichi Sankyo Inc. | 5 | $118 |
| Johnson & Johnson | 7 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $108 |
| Lilly USA, LLC | 8 | $104 |
| Esperion Therapeutics, Inc. | 6 | $92 |
| Sanofi-aventis U.S. LLC | 5 | $85 |
| Eisai Inc. | 6 | $85 |
| Astellas Pharma US Inc | 5 | $84 |
| Abbott | 3 | $65 |
| Supernus Pharmaceuticals, Inc. | 2 | $61 |
| Scilex Pharmaceuticals Inc. | 4 | $52 |
| Genentech USA, Inc. | 3 | $49 |
| Hikma Pharmaceuticals USA | 4 | $47 |
| Amgen | 3 | $45 |
| Philips North America LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Novartis | 1 | $12 |
| Merck | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
How this compares
$2,956 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Denver
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.